Enasidenib Mesylate and Tyvaso

• Generic Name: enasidenib
• Dosage Forms: n.a.
• Other Brand Names: Idhifa, Idhifa

For the treatment of relapsed or refractory AML with IDH2 mutation (designated an orphan drug by FDA for this use).

FDA-approved diagnostic test (e.g., Abbott RealTime IDH2 assay) required to confirm the presence of IDH2 mutation prior to initiation of therapy.

• Generic Name: treprostinil
• Dosage Forms: inhalation solution
• Other Brand Names: Tyvaso, Tyvaso Refill Kit, Tyvaso Starter Kit, Orenitram, Remodulin

Tyvaso (treprostinil) dilates (widens) the arteries and decreases the amount of blood clotting platelets in your body. These effects lower blood pressure in the pulmonary artery that leads from the heart to the lungs.

Tyvaso is used to treat pulmonary arterial hypertension (PAH). This medicine improves your ability to exercise and can help prevent your condition from getting worse.

Tyvaso may also be used for purposes not listed in this medication guide.